Reports
CHANGING LIFESTYLES TO STOKE MORE GROWTH IN PHARMACEUTICALS
Total Reports: 495
The primary drivers to the expanding psychotropic drugs market include the rising prevalence of mental disorders such as depression, schizophrenia, anxiety, bipolar disorders, ADHD, and the other mental disorders. In addition, the awareness about mental disorders has reduced the stigma related to mental illnesses.
Rep Id : TMRGL79453 | Published | Pharmaceutical | January 2026
CAR T-cell therapy, as a method specifically engineered to exploit patients' immune system against tumor cells, constitutes a revolutionary technology in cancer care and is progressively being considered in solid tumors apart from hematological malignancies
Rep Id : TMRGL83242 | Published | Pharmaceutical | January 2026
The factors resulting in the development of hypertrophic cardiomyopathy (HCM) therapeutics market include the awareness of the disease and its diagnosis, together with technological improvements in cardiac imaging, facilitating diagnosis of the disease at an early stage and with higher accuracy.
Rep Id : TMRGL7553 | Published | Pharmaceutical | January 2026
Increased use of companion diagnostics and robust development of biomarker testing lead to better patient stratification, which, in turn, implies that a greater number of targeted therapies are utilized.
Rep Id : TMRGL504 | Published | Pharmaceutical | January 2026
Several factors are driving the growth of the opioid-induced constipation treatment market for both - clinical and outpatient settings.
Rep Id : TMRGL6862 | Published | Pharmaceutical | January 2026
Regulatory harmonization and reimbursement-friendly policies drive the market growth, facilitating access by more patients and inclusion of formularies.
Rep Id : TMRGL86927 | Published | Pharmaceutical | January 2026
Improved insurance coverage and increasing healthcare expenditure have expanded access to therapies and propelled affordability, thus driving growth of the asthma and COPD drugs market.
Rep Id : TMRGL86923 | Published | Pharmaceutical | January 2026
India animal healthcare sector has seen robust expansion, driven by a rising awareness of animal health and increasing disposable incomes.
Rep Id : TMRGL23048 | Published | Pharmaceutical | December 2025
Adoption of intraoperative radiation therapy is driven by growing demand for single-session treatments, short hospitalization, and quick recovery, which is in congruence with value-based care models.
Rep Id : TMRGL74059 | Published | Pharmaceutical | December 2025
GLP-1 analogues market is driven by strong clinical evidence demonstrating benefits to the cardiovascular and metabolic systems, growing healthcare spending, and extended reimbursement plans that further enhance patient access.
Rep Id : TMRGL86893 | Published | Pharmaceutical | December 2025
The growth of the T-cell lymphoma (TCL) therapeutics market for is expected to be significant, which is attributed to the array of available treatments based on therapeutics advances inclusive of targeted therapies and immunotherapies.
Rep Id : TMRGL86859 | Published | Pharmaceutical | December 2025
The non-cystic fibrosis bronchiectasis treatment market is witnessing vigorous expansion owing to multiple compelling drivers.
Rep Id : TMRGL86850 | Published | Pharmaceutical | November 2025
The global kidney cancer drugs market is expected to go steady due to the continuous development in targeted therapies and immuno-oncology, increasing aging population, and wider access to diagnostic testing, which make it possible to give the patients earlier and more personalized treatment.
Rep Id : TMRGL537 | Published | Pharmaceutical | November 2025
Increased diagnostic accuracy and wider availability of high-end ocular imaging are significant drivers to the uveal melanoma treatment market.
Rep Id : TMRGL86847 | Published | Pharmaceutical | November 2025
The key factors driving the growth of sarcopenia treatment market are the aging global population, raised awareness of and diagnosis of sarcopenia, the ongoing influx of nutritional supplementation into mainstream, and the emergence of pharmacological therapies such as myostatin inhibitors and SARMs.
Rep Id : TMRGL28547 | Published | Pharmaceutical | November 2025
Multiple key factors drive the expansion of the Barth syndrome therapeutics market.
Rep Id : TMRGL86829 | Published | Pharmaceutical | November 2025
A number of driving forces fuel acromegaly treatment market growth.
Rep Id : TMRGL86824 | Published | Pharmaceutical | November 2025
The global market for controlled drugs steadily expands with the main driver being the escalating cases of chronic pain, neurological disorders, and psychiatric conditions that need medications that are regulated by the authorities.
Rep Id : TMRGL25964 | Published | Pharmaceutical | November 2025
Parenteral nutrition industry is fueled by several key drivers including the growing prevalence of chronic diseases, hospitalization, and advancements in medical technology.
Rep Id : TMRGL3611 | Published | Pharmaceutical | November 2025
The abortion drugs market grows at the convergence of clinical practice, regulatory diligence, and shifting distribution models.
Rep Id : TMRGL86809 | Published | Pharmaceutical | November 2025
The global oral proteins & peptides market is growing significantly due to the advent of technology that can effectively deliver biologics orally.
Rep Id : TMRGL1962 | Published | Pharmaceutical | October 2025
The synthetic cannabinoids market is undergoing acceleration towing to the increased use of cannabinoids-based drugs in various therapies.
Rep Id : TMRGL74674 | Published | Pharmaceutical | October 2025
The monogenetic disease therapy market is witnessing transformative developments due to extensive research being conducted regarding gene-based treatments transitions medicine into a new frontier of therapeutic choices.
Rep Id : TMRGL86769 | Published | Pharmaceutical | October 2025
The global fish collagen peptides market is expected to witness steadiness throughout the forecast period, mainly through consumer understanding of the hex-food-wellness-beauty sector.
Rep Id : TMRGL68918 | Published | Pharmaceutical | October 2025
The bioinformatics market works on a spectrum between biology and data science.
Rep Id : TMRGL656 | Published | Pharmaceutical | October 2025
The clinical trials market is being driven by a combination of factors including increasing R&D budgets, shorter clinical timelines, and regulatory initiatives to facilitate easier study initiation.
Rep Id : TMRGL78053 | Published | Pharmaceutical | September 2025
The anti-infective drug market is witnessing an upward trajectory as scientific technology advancements toward the development of therapeutic agents become more universally accepted.
Rep Id : TMRGL41204 | Published | Pharmaceutical | September 2025
The global erectile dysfunction medicines market is experiencing consistency, buoyed by rising incidences of lifestyle disorders including diabetes, hypertension, obesity, and cardiovascular ailments-prime causes of erectile dysfunction.
Rep Id : TMRGL1550 | Published | Pharmaceutical | August 2025
The market for collagen peptides and gelatin has witnessed an astounding growth in the past two years, with an increasing consumer knowledge of the health and well-being associated with the product.
Rep Id : TMRGL1070 | Published | Pharmaceutical | August 2025
The ophthalmic drug market is currently witnessing robust growth because of increased prevalence of eye diseases, advancements in pharmaceutical technology, and enhanced global awareness of the importance of eye care. One of the major reasons for this market expansion is rise in the prevalence of eye disorders.
Rep Id : TMRGL1769 | Published | Pharmaceutical | July 2025
Most comprehensive coverage 100+ countries, 2 million+ data points
Personalized pre-sales, on-boarding, and post-sales support
Less assumption, more science - a research methodology perfected through years of rigorous diligence
True to its name, transparency in every minute details from research processes to financials
20% of Fortune 500 are our clients have worked with over 3000 SMEs